BRPI0913949A2 - preparação e composição de proteínas inibidoras inter-alfa a partir de sangue - Google Patents

preparação e composição de proteínas inibidoras inter-alfa a partir de sangue

Info

Publication number
BRPI0913949A2
BRPI0913949A2 BRPI0913949A BRPI0913949A BRPI0913949A2 BR PI0913949 A2 BRPI0913949 A2 BR PI0913949A2 BR PI0913949 A BRPI0913949 A BR PI0913949A BR PI0913949 A BRPI0913949 A BR PI0913949A BR PI0913949 A2 BRPI0913949 A2 BR PI0913949A2
Authority
BR
Brazil
Prior art keywords
inter
blood
preparation
composition
alpha inhibitor
Prior art date
Application number
BRPI0913949A
Other languages
English (en)
Inventor
Edward S Sirya
Peter Brne
Yow-Pin Lim
Original Assignee
Pro Thera Biolog Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Thera Biolog Llc filed Critical Pro Thera Biolog Llc
Priority to BR122020017577-0A priority Critical patent/BR122020017577B1/pt
Publication of BRPI0913949A2 publication Critical patent/BRPI0913949A2/pt
Publication of BRPI0913949B1 publication Critical patent/BRPI0913949B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0913949-4A 2008-05-28 2009-05-28 Composição farmacêutica compreendendo proteínas inibidoras inter- alfa purificadas BRPI0913949B1 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR122020017577-0A BR122020017577B1 (pt) 2008-05-28 2009-05-28 Método para purificar proteínas inibidoras inter-alfa

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13026908P 2008-05-28 2008-05-28
US61/130,269 2008-05-28
PCT/US2009/003291 WO2009154695A1 (en) 2008-05-28 2009-05-28 Preparation and composition of inter-alpha inhibitor proteins from blood

Publications (2)

Publication Number Publication Date
BRPI0913949A2 true BRPI0913949A2 (pt) 2015-10-20
BRPI0913949B1 BRPI0913949B1 (pt) 2026-02-24

Family

ID=

Also Published As

Publication number Publication date
KR20170116196A (ko) 2017-10-18
JP6309915B2 (ja) 2018-04-11
JP2018008941A (ja) 2018-01-18
CN106928346B (zh) 2021-09-07
PT2291654T (pt) 2018-06-15
CN102112876B (zh) 2017-12-08
JP5793076B2 (ja) 2015-10-14
CA2726281C (en) 2023-04-18
TR201808152T4 (tr) 2018-07-23
KR101714008B1 (ko) 2017-03-09
US9758570B2 (en) 2017-09-12
KR20160129914A (ko) 2016-11-09
WO2009154695A1 (en) 2009-12-23
US9139641B2 (en) 2015-09-22
CA2726281A1 (en) 2009-12-23
US20170157224A1 (en) 2017-06-08
CN102112876A (zh) 2011-06-29
EP2291654B1 (en) 2018-04-11
AU2009260822A1 (en) 2009-12-23
EP2291654A4 (en) 2011-08-24
BR122020017577B1 (pt) 2021-10-26
JP2011524343A (ja) 2011-09-01
EP2291654A1 (en) 2011-03-09
JP2015155434A (ja) 2015-08-27
CN106928346A (zh) 2017-07-07
KR101828433B1 (ko) 2018-03-29
US20110190194A1 (en) 2011-08-04
US20160145318A1 (en) 2016-05-26
KR20110053404A (ko) 2011-05-23
DK2291654T3 (en) 2018-06-14
ES2673005T3 (es) 2018-06-19
AU2009260822B2 (en) 2016-09-22
US10076559B2 (en) 2018-09-18

Similar Documents

Publication Publication Date Title
PT2291654T (pt) Preparação e composição de proteínas inibidoras de interalfa do sangue
DK2379600T4 (da) Antistoffer mod tissue factor pathway inhibitor
FR16C1026I2 (fr) Inhibiteurs de la replication du virus de l'hepatite c
EP2377028A4 (en) CHANGE OF COMMANDS
DK2041270T3 (da) Fremstilling af glycoproteiner
PT2376537T (pt) Anticorpos humanos contra fator tecidual humano
EP2272817A4 (en) PAI-1 INHIBITORS
DK2231606T3 (da) Fremgangsmåder til fremstilling af cycloalkylcarboxamidopyridinbenzoesyrer
EP2092445A4 (en) NEGOTIATING SEARCH RESULTS
PT2376533T (pt) Formulação de anticorpos
EP2356139A4 (en) LIGURE COMBINED POLYPEPTIDES
IL208979B (en) Humanized antibodies against human interferon-alpha
EP2103262A4 (en) sewing needle
DK2034830T3 (da) Anti-vla-1-antistof til behandling af slagtilfælde
EP2463316A4 (en) acrylate composition
BRPI0907109A2 (pt) lenço dental e método
EP2237793A4 (en) CATHEPSIN-B INHIBITORS
EP2110789A4 (en) PAPER MONEY PROCESSOR
IL192319A (en) Assessment of medical conditions
DK2154149T3 (da) En trunkeret l1-protein af human papillomavirus 6
DE602007014179D1 (de) Herstellung von polytrimethylen-etherglykol
IT1395539B1 (it) Piede d'appoggio
EP2462237A4 (en) METHOD FOR IMPROVING THE EXPRESSION OF RECOMBINANT PROTEINS
DK2005182T3 (da) Kliniske korrelater
EP2350857A4 (en) BOOTSTRAP REDENZVOUSPUNKTERING

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: PROTHERA BIOLOGICS, INC. (US)

B25G Requested change of headquarter approved

Owner name: PROTHERA BIOLOGICS, INC. (US)

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/05/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.